Inceptua’s Edoardo Madussi shares his insights The case in favour of running a global clinical trial is compelling: lower running costs, quicker timelines, and access to substantially larger patient populations…
Pre-approval access is evolving at a rapid pace. Mark Corbett, Executive Vice President of Medicines Access at Inceptua, gives you an overview of the key benefits of utilizing pre-approval access…